Back
BioCryst Pharmaceuticals Stock Price Chart
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
40
BCRX
BioCryst Pharmaceuticals
Last Price:
7.87
Seasonality Move:
8.45%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BioCryst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.56 | Buy |
| 20-day SMA: | 7.47 | Buy |
| 50-day SMA: | 7.6 | Buy |
| 200-day SMA: | 6.67 | Buy |
| 8-day EMA: | 7.64 | Buy |
| 20-day EMA: | 7.57 | Buy |
| 50-day EMA: | 7.59 | Buy |
| 200-day EMA: | 7.13 | Buy |
BioCryst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 56.61 | Buy |
| Chaikin Money Flow: | 998725 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.22 - 7.8) | Buy |
| Bollinger Bands (100): | (7.33 - 8.07) | Buy |
BioCryst Pharmaceuticals Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioCryst Pharmaceuticals Stock
Is BioCryst Pharmaceuticals Stock a Buy?
- BioCryst Pharmaceuticals share price is 7.93 while BCRX 8-day simple moving average is 7.56, which is a Buy signal.
- The stock price of BCRX is 7.93 while BioCryst Pharmaceuticals 20-day SMA is 7.47, which makes it a Buy.
- BioCryst Pharmaceuticals 50-day simple moving average is 7.60 while BCRX share price is 7.93, making it a Buy technically.
- BCRX stock price is 7.93 and BioCryst Pharmaceuticals 200-day simple moving average is 6.67, creating a Buy signal.
BCRX Technical Analysis vs Fundamental Analysis
Sell
40
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy or a Sell?
-
BioCryst Pharmaceuticals stock is rated a Sell
The current BioCryst Pharmaceuticals [BCRX] share price is $7.93. The Score for BCRX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
BioCryst Pharmaceuticals Stock Info
Market Cap:
1.64B
Price in USD:
7.93
Share Volume:
1.77M
BioCryst Pharmaceuticals 52-Week Range
52-Week High:
8.88
52-Week Low:
4.03
Sell
40
BioCryst Pharmaceuticals (BCRX)
is a Sell
BioCryst Pharmaceuticals Share Price Forecast
-
What is the BioCryst Pharmaceuticals stock price today?
The BioCryst Pharmaceuticals stock price is 7.93 USD today. -
Will BCRX stock go up or go down?
BioCryst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is BioCryst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioCryst Pharmaceuticals is overvalued.
Is BioCryst Pharmaceuticals Stock a Buy?
- BioCryst Pharmaceuticals share price is 7.93 while BCRX 8-day exponential moving average is 7.64, which is a Buy signal.
- The stock price of BCRX is 7.93 while BioCryst Pharmaceuticals 20-day EMA is 7.57, which makes it a Buy.
- BioCryst Pharmaceuticals 50-day exponential moving average is 7.59 while BCRX share price is 7.93, making it a Buy technically.
- BCRX stock price is 7.93 and BioCryst Pharmaceuticals 200-day simple moving average is 7.13, creating a Buy signal.
Fundamental Analysis of BioCryst Pharmaceuticals
Is BioCryst Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.32 per share.
Technical Analysis of BioCryst Pharmaceuticals
Should I short BioCryst Pharmaceuticals stock?
- BCRX Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting BioCryst Pharmaceuticals is a Buy
- BioCryst Pharmaceuticals Relative Strength Index (RSI) is 56.61, which suggest BioCryst Pharmaceuticals is overbought
- The Bollinger Bands (25) for BioCryst Pharmaceuticals is (7.22 - 7.8), which suggest BioCryst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for BioCryst Pharmaceuticals is (7.33 - 8.07), which suggest BioCryst Pharmaceuticals is a Buy
* BioCryst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.